Tags: Drug.
Rituximab (trade names Rituxan MabThera and Zytux) is a chimeric monoclonal antibody against the protein CD20 which is primarily found on the surface of immune system B cells. Rituximab destroys B cells and is therefore used to treat diseases which are characterized by excessive numbers of B cells overactive B cells or dysfunctional B cells. This includes many lymphomas leukemias transplant rejection and autoimmune disorders.
